<?xml version="1.0" encoding="UTF-8"?>
<p>Through the Rapid Alert Network procedure, MSs, EMA, the EC, and other relevant partners (eg, international organizations and non‚ÄêEU RAs) exchange quality information mainly on recalls of medicinal products, due to quality defects or falsification that may result in illness, suboptimal or inappropriate treatment, or threat to life.</p>
